Gardner syndrome a hereditary disorder characterised by the growth of multiple benign tumours and polyps in the colon and other areas of the body. It is a subtype of familial adenomatous polyposis (FAP), caused by mutations in the APC gene. If not treated early, the intestinal polyps associated with this condition can become cancerous, particularly leading to colorectal cancer. Understanding this syndrome is crucial for early detection and prevention.
Gardner syndrome is a rare autosomal dominant genetic condition. It typically causes hundreds to thousands of polyps in the lining of the large intestine. These polyps begin to develop during teenage years or early adulthood and, if untreated, almost always progress to colorectal cancer by the age of 40 or 50. Besides gastrointestinal issues, individuals may develop non-cancerous tumours in the skin, bones, and soft tissues, such as epidermoid cysts and desmoid tumours.
Gardner syndrome is an extremely rare condition. Globally, familial adenomatous polyposis (FAP), which includes Gardner syndrome, affects approximately 1 in 10,000 to 1 in 30,000 individuals. In India, limited data exists, but studies suggest that the incidence may be underreported due to lack of awareness and genetic testing.
Gardner syndrome a variant of familial adenomatous polyposis (FAP), and while it is not subdivided into further types, it can be categorised based on symptoms:
The primary cause of Gardner syndrome is a mutation in the adenomatous polyposis coli (APC) gene located on chromosome 5. This gene mutation leads to abnormal cell growth, resulting in polyps and other tumours. The disorder follows an autosomal dominant inheritance pattern, which means a person only needs to inherit one defective copy of the gene from one parent to be affected.
In some cases, new (de novo) mutations can occur without a family history.
Symptoms may vary depending on the organs affected, but common signs include:
Early diagnosis is vital to reduce cancer risk. The diagnostic process may include:
Family members of an affected individual are often advised to undergo screening by age 10-12.
Treatment of Gardner syndrome
There is no cure for Gardner syndrome, but early and ongoing treatment can help prevent complications.
While alternative therapies cannot cure Gardner syndrome, they may support overall wellbeing:
The primary risk factor is family history. Individuals with a parent carrying the APC gene mutation have a 50% chance of inheriting the condition. Other risk factors include:
If left untreated, Gardner syndromecan lead to serious complications:
Seek medical attention if you:
Early screening can prevent serious complications.
Gardner syndrome is a life-altering yet manageable genetic condition. With early detection, regular screening, and timely treatment, individuals can lead fulfilling lives while significantly reducing their cancer risk. Genetic counselling and family awareness are essential for prevention. Understanding the condition, busting myths, and providing holistic support can make a lasting impact on those living with Gardner syndrome.